L1CAM and ovarian cancer: In a clinical setting, analysis of L1CAM mRNA levels in 138 ovarian cancer patients identified L1CAM expression as an independent predictor of disease progression and overall survival, highlighting its significant role in ovarian cancer pathophysiology and its association with poor clinical outcomes [12].